THSD7A and autoimmune disease: In most patients, MN is an autoimmune disease mediated by autoantibodies directed against phospholipase A2 receptor (PLA2R) or, more unusually, thrombospondin type-1 domain-containing 7A (THSD7A) (Deng et al., 2021).